Scenario
A pharmaceutical company is developing a new treatment for asthma. Several therapies are already available that have substantial
efficacy associated with a good safety profile. Short term Phase I and Phase II studies have shown that the new drug is well
tolerated and has a modest bronchodilator action at the low doses that have been tested.
Now answer the questions associated with this case study.
